中文 EN

News

news

position：Home > News

2026-07-16

Cygnus Biosciences Showcases High-Performance Sequencing Solutions at WHX Bangkok 2026

Bangkok, Thailand, July 9, 2026 Cygnus Biosciences (Beijing) Co., Ltd., an innovator dedicated to developing proprietary sequencing technologies and platforms that power the future of sequencing, is showcasing its high-performance, user-centric sequencing... ...

more

07-162026

Cygnus Biosciences Showcases High-Performance Sequencing Solutions at WHX Bangkok 2026

Bangkok, Thailand, July 9, 2026 Cygnus Biosciences (Beijing) Co., Ltd., an innovator dedicated to developing proprietary sequencing technologies and platforms that power the future of sequencing, is showcasing its high-performance, user-centric sequencing... ...

MORE >>

07-152026

Cygnus Biosciences Repeatedly Listed in Top 100 Future Healthcare Enterprises

Arterial Network unveiled the 2026 Top 100 Future Healthcare Enterprise Rankings recently. Boasting outstanding technological prowess and sustained innovation strength in indigenous original gene sequencing technology, Cygnus Biosciences has once again se... ...

MORE >>

07-152026

Cygnus Bio Launches New Sequencing System GS200

On March 21, 2025, Cygnus Bio launched its new Sequencing System GS200 (S200). With its ultra-fast sequencing speed of 4 hours, wide library compatibility, excellent sequencing accuracy and convenient on-machine process, the sequencer has significantly im... ...

MORE >>

04-032026

Cygnus Biosciences Original Sequencing Platform Empowers Single-Cell Omics; Experimental Data Demonstrates Sequencing Capabilities

Recent experimental data has further robustly validated the GP1000 platform’s outstanding performance in single-cell transcriptomics.... ...

MORE >>

03-242026

Cygnus Bio Concludes Successful Appearance at CACLP 2026 in Xiamen, China

At this year’s exhibition, Cygnus Bio systematically showcased its Product Line S (GS100/GS200) and Product Line P (GP1000/GP1000X) gene sequencers, which cater to diverse application scenarios. The display highlighted the company’s breakthroughs in core ... ...

MORE >>

01-272026

Cygnus Bio GP1000 Empowers Single-Cell Transcriptome Research with High Precision in Unraveling T-Cell Exhaustion and Memory Heterogeneity

As biomedical research enters the single-cell era, high-throughput sequencing depth and high-quality data output have become the cornerstone for dissecting complex cellular landscapes. Under its OpenSeq Initiative, Cygnus Biosciences (Beijing) Co., Ltd. a... ...

MORE >>